Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
InChiKey: KXGCNMMJRFDFNR-WDRJZQOASA-N
GSK 3117391A
It is in a phase 3 clinical trial for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
with rapid clearance and barely measurable bioavailability
RGB-286638 Size:Solid 2 mg InChiKey: KXGCNMMJRFDFNR-WDRJZQOASA-NRGB 286638 is a multitargeted cyclin dependent kinase inhibitor. RGB 286638 triggers P53 dependent and independent anti multiple myeloma activity through inhibition of transcriptional CDKs. GB 286638 treatment resulted in MM cytotoxicity in vitro associated with inhibition of MM tumor growth and prolonged survival in vivo. RGB 286638 displayed caspase dependent apoptosis in both wt p53 and mutant p53 cells that was closely associated with the
US$ 132.00
US$ 105.00
US$ 104.50
US$ 478.00
US$ 134.00
US$ 192.00
US$ 95.00